Related Experiment Videos
Myocardial injury produced by antineoplastic drugs
Abstract:
Histologic and ultrastructural studies were performed on the heart of 16 patients with fatal leukemias or solid tumors. Multifocal myocardial degenerative lesions, characterized by alterations in contractile elements, mitochondria, and nuclei, were found in 12 patients treated with high total doses of anthracyclines, but not in 3 patients who did receive such therapy. One patient who received a high dose of cyclophosphamide as well as a high total dose of daunorubicin exhibited extensive hemorrhagic myocardial necrosis and multifocal degenerative lesions. This study documents the cardiotoxic effects of anthracyclines and cyclophosphamide.
Insights
High-dose anthracyclines and cyclophosphamide can cause significant heart damage in cancer patients. These chemotherapy drugs led to myocardial degenerative lesions and necrosis in a recent histologic study.
Area of Science:
- Cardiology
- Oncology
- Pathology
Background:
- Cancer therapies, including anthracyclines and cyclophosphamide, are associated with potential cardiotoxicity.
- Understanding the specific cardiac manifestations of these treatments is crucial for patient management.
Purpose of the Study:
- To investigate the histologic and ultrastructural cardiac effects of high-dose anthracyclines and cyclophosphamide in patients with fatal leukemias or solid tumors.
Main Methods:
- Histologic and ultrastructural examination of myocardial tissue from 16 patients with fatal malignancies.
- Correlation of cardiac findings with chemotherapy treatment regimens, specifically anthracycline and cyclophosphamide doses.
Main Results:
- Multifocal myocardial degenerative lesions were observed in 12 of 13 patients treated with high-dose anthracyclines.
- One patient receiving high-dose cyclophosphamide and daunorubicin showed extensive hemorrhagic myocardial necrosis.
- Cardiac damage was absent in a control group of 3 patients not receiving high-dose therapy.
Conclusions:
- High total doses of anthracyclines are associated with significant cardiotoxic effects, manifesting as myocardial degenerative lesions.
- Concomitant high-dose cyclophosphamide and anthracyclines can lead to severe cardiac pathology, including necrosis.
- This study highlights the detrimental impact of specific chemotherapy agents on cardiac tissue.